Showing results (381-390 of 401) with videos related to

Sort By:
Pageof 41
The Journal of Clinical Investigation|September 10, 2024
Antibiotic use during influenza infection augments lung eosinophils that impair immunity against secondary bacterial pneumoniaMarilia Sanches Santos Rizzo Zuttion, Tanyalak Parimon, Stephanie A Bora, et al.
Science (New York, N.Y.)|March 6, 2025
Macrophage peroxisomes guide alveolar regeneration and limit SARS-CoV-2 tissue sequelaeXiaoqin Wei, Wei Qian, Harish Narasimhan, et al.
Journal of Critical Care|November 15, 2024
Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19Laurence W Busse, J Pedro Teixeira, Christopher L Schaich, et al.
JCI Insight|September 24, 2024
Fibroblast-derived extracellular vesicles contain SFRP1 and mediate pulmonary fibrosisOlivier Burgy, Christoph H Mayr, Déborah Schenesse, et al.
Plos One|July 24, 2020
Pre-existing traits associated with Covid-19 illness severityJoseph E Ebinger, Natalie Achamallah, Hongwei Ji, et al.
BMJ Open|May 25, 2022
Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysisJoseph E Ebinger, Sandy Joung, Yunxian Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2021
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral LoadMichael Dougan, Masoud Azizad, Bharat Mocherla, et al.
The New England Journal of Medicine|July 14, 2021
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19Michael Dougan, Ajay Nirula, Masoud Azizad, et al.
Nature|September 4, 2024
An aberrant immune-epithelial progenitor niche drives viral lung sequelaeHarish Narasimhan, In Su Cheon, Wei Qian, et al.
The Lancet. Microbe|May 30, 2024
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort studyTomas O Jensen, Thomas A Murray, Greg A Grandits, et al.
Pageof 41